HAMILTON, ON, January 20, 2021 / – Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced the launch of its new multilingual Interactive Voice Recognition product, iUGO Care IVR, and a new contract with a physician practice in Maryland to use iUGO Care IVR with both their English- and Russian-speaking patients.

“We have incorporated Interactive Voice Recognition (IVR) in the iUGO Care platform to support patients who are using their own, non-connected monitoring devices, have cellular or internet connectivity challenges or simply prefer an automated daily phone call in the language of their choice as a reminder to collect their vitals,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.  “The new product uses Interactive Voice Recognition to communicate with patients in any language, record patients’ self-reported readings and automatically upload the data to the iUGO Care platform, where it can be accessed by their care team. This solution is of particular interest to private insurers and employer-sponsored insurance plans who want patients to use their existing, non-connected biometric monitoring devices. Clinicians can also leverage existing Medicare reimbursement codes for Remote Patient Monitoring involving self-reported data.  This is a highly scalable product that will allow us to serve a large patient population that was not previously addressed by standard Remote Patient Monitoring technology.”

The Company has signed a new contract with a physician practice in Maryland to provide Remote Patient Monitoring with Interactive Voice Recognition to a significant Russian-speaking patient population.  Onboarding started in Maryland this week.  The Company expects to expand the IVR product offering into additional geographies requiring a variety of different languages later this quarter.

About Reliq Health

Reliq Health Technologies is a rapidly growing global telemedicine that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery.  iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.  Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.


“Dr. Lisa Crossley”

CEO and Director

For further information please contact:

Company Contact

Investor Relations at ir@reliqhealth.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.